Aion Therapeutic Inc. (CSE:AION)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Sep 3, 2025, 2:05 PM EST

Aion Therapeutic Cash Flow Statement

Millions CAD. Fiscal year is May - Apr.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20
Net Income
-6.65-6.29-0.26-3.82-8.27-0.67
Depreciation & Amortization
0.120.040.020.070.130.11
Other Amortization
----0.060.08
Asset Writedown & Restructuring Costs
2.012.01-0.2515.14-
Loss (Gain) From Sale of Investments
0.010.010.11---
Stock-Based Compensation
----0.46-
Provision & Write-off of Bad Debts
----0.02-
Other Operating Activities
3.193.02-0.420.070.09-0.34
Change in Accounts Receivable
-0.120.01----
Change in Inventory
-0.03-0.08----
Change in Accounts Payable
-0.010.280.81.190.420
Change in Other Net Operating Assets
-0.080.13-0.050.15-0.20.27
Operating Cash Flow
-1.55-0.85-0.04-1.35-2.13-0.55
Capital Expenditures
------0.2
Sale of Property, Plant & Equipment
--0.14---
Sale (Purchase) of Intangibles
-----1.44-
Other Investing Activities
----0.06-
Investing Cash Flow
--0.290.14--1.38-0.2
Short-Term Debt Issued
-0.040.240.68--
Total Debt Issued
0.720.040.240.68--
Short-Term Debt Repaid
---0.16-0.5--
Long-Term Debt Repaid
--0.03-0.02-0.07-0.27-0.25
Total Debt Repaid
-0.29-0.03-0.17-0.57-0.27-0.25
Net Debt Issued (Repaid)
0.4200.060.11-0.27-0.25
Issuance of Common Stock
0.991.090.11.113.32-
Other Financing Activities
-00.03--0.03-0.04-
Financing Cash Flow
1.411.120.161.23-0.25
Foreign Exchange Rate Adjustments
-0.20.08-0.26-0.090.14-
Net Cash Flow
-0.340.070-0.24-0.37-1.01
Free Cash Flow
-1.55-0.85-0.04-1.35-2.13-0.76
Free Cash Flow Margin
-104.95%-229.96%----
Free Cash Flow Per Share
-0.00-0.00--0.01-0.02-0.02
Cash Interest Paid
----0.010.02
Levered Free Cash Flow
-1.36-0.52-0.51-0.22-2.24-0.62
Unlevered Free Cash Flow
-1.15-0.41-0.41-0.17-2.19-0.5
Change in Working Capital
-0.240.350.751.340.230.27
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.